510(k) K230263
K230263 is an FDA 510(k) premarket notification submitted by Summa Therapeutics, LLC for the device "Finesse Injectable PTA Balloon Dilatation Catheter". The FDA issued a decision of Substantially Equivalent on May 26, 2023. The device falls under product code LIT (Catheter, Angioplasty, Peripheral, Transluminal), a Class II device regulated under 21 CFR 870.1250. Summa Therapeutics, LLC has at least 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 26, 2023
- Date Received
- January 31, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Catheter, Angioplasty, Peripheral, Transluminal
- Device Class
- Class II
- Regulation Number
- 870.1250
- Review Panel
- CV
- Submission Type